Want to see CRVS full AI Analyst Report?
Corvus Pharmaceuticals (CRVS) Ownership Overview
13.83% Insiders
12.11% Mutual Funds
3.55% Other Institutional Investors
14.17% ETFs
56.33% Public Companies and
Individual Investors
The ownership structure of Corvus Pharmaceuticals (CRVS) stock is a mix of institutional, retail, and individual investors. Approximately 29.83% of the company’s stock is owned by Institutional Investors, 13.83% is owned by Insiders, and 56.33% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 15, 2026 | xxxxxxxxxxxxx | $250201 | |
May 20, 2026 | xxxxxxxxxxxxx | $83453 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $1024100 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $33538412 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $6583500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,819,091 | Insider | 10.48% | 121,174,310 | |
| 4,046,794 | Institution | 4.81% | 55,602,950 | |
| 3,578,375 | Institution | 4.25% | 49,166,873 | |
| 3,196,113 | Institution | 3.80% | 43,914,593 | |
| 3,159,968 | Institution | 3.76% | 43,417,960 | |
| 2,331,742 | Insider | 2.77% | 32,038,135 | |
| 2,292,441 | Institution | 2.73% | 31,498,139 | |
| 744,094 | Institution | 0.88% | 10,223,852 | |
| 734,142 | Institution | 0.87% | 10,087,111 | |
| 725,099 | Institution | 0.86% | 9,962,860 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,159,968 | Institution | 3.76% | 43,417,960 | |
| 744,094 | Institution | 0.88% | 10,223,852 | |
| 734,142 | Institution | 0.87% | 10,087,111 | |
| 725,099 | Institution | 0.86% | 9,962,860 | |
| 722,282 | Institution | 0.86% | 9,924,155 | |
| 697,114 | Institution | 0.83% | 9,578,346 | |
| 621,357 | Institution | 0.74% | 8,537,445 | |
| 550,000 | Institution | 0.65% | 7,557,000 | |
| 340,809 | Institution | 0.41% | 4,682,716 | |
| 233,476 | Institution | 0.28% | 3,207,960 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,945,899 | Institution | 3.50% | 41,006,914 | |
| 2,374,106 | Institution | 2.82% | 35,469,144 | |
| 1,735,953 | Institution | 2.06% | 24,164,466 | |
| 844,478 | Institution | 1.00% | 12,616,501 | |
| 620,432 | Institution | 0.74% | 8,636,413 | |
| 467,057 | Institution | 0.56% | 6,501,433 | |
| 390,005 | Institution | 0.46% | 5,826,675 | |
| 229,721 | Institution | 0.27% | 3,197,716 | |
| 218,716 | Institution | 0.26% | 3,005,158 | |
| 189,601 | Institution | 0.23% | 2,832,639 |
FAQ
Who Owns Corvus Pharmaceuticals Inc (CRVS)?
According to the latest TipRanks data, approximately 3.55% of the company's stock is held by institutional investors, 13.83% is held by insiders, and 56.33% is held by retail investors.
What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.55% of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors.
What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.33% of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors.
Who owns the most shares of Corvus Pharmaceuticals Inc (CRVS)?
Peter A. Thompson owns the most shares of Corvus Pharmaceuticals Inc (CRVS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.